Cargando…
AMCP Partnership Forum: Biosimilars—Ready, Set, Launch
SUMMARY: Through 2020, reference biologic products will lose patent protection that will be worth $54 billion to the U.S. economy. Consequently, interest in biosimilars is intensifying across the health care industry. Managed care organizations (MCOs) are depending on the savings opportunity that bi...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398129/ https://www.ncbi.nlm.nih.gov/pubmed/27023697 http://dx.doi.org/10.18553/jmcp.2016.22.4.434 |